These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice. Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494 [TBL] [Abstract][Full Text] [Related]
8. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes. Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807 [TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2. Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610 [TBL] [Abstract][Full Text] [Related]
10. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes. Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750 [TBL] [Abstract][Full Text] [Related]
11. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation. Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454 [TBL] [Abstract][Full Text] [Related]
12. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis. Shah YM; Morimura K; Gonzalez FJ Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756 [TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines. Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664 [TBL] [Abstract][Full Text] [Related]
20. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis. Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]